Trial intelligence / Profile preview

Bioequivalence Study of Generic Nebivolol 5 mg Tablets vs NEBILET in Healthy Thai Volunteers under Fasting

TCTR20250522003Phase 1Unknown

Sponsor
International Bio Service
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of nebivolol (2 arms), sponsored by International Bio Service. Status: unknown.

02

Drugs

nebivolol

Beyond the preview

Go deeper on TCTR20250522003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250522003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call